PriceTargets.com logo

RTW Biotech Opportunities - RTW Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: GBX 0
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
GBX 1.31 As of 04/24/2024 01:00 AM ET
▼ -0.01 (-0.76%)

This chart shows the closing price for RTW by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New RTW Biotech Opportunities Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for RTW and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for RTW

Analyst Price Target is GBX 0
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for RTW Biotech Opportunities in the last 3 months. The average price target is GBX 0, with a high forecast of GBX 0 and a low forecast of £100,000. The average price target represents a -100.00% upside from the last price of GBX 1.31.

This chart shows the closing price for RTW for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in RTW Biotech Opportunities. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/1/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/30/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/30/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/29/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/27/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/25/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/25/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/24/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
2/7/2023Jefferies Financial GroupLower TargetBuyGBX 413 ➝ GBX 388
(Data available from 4/24/2019 forward)

News Sentiment Rating

-0.04 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/27/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/27/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/26/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/26/2023
  • 0 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
1/25/2024
  • 1 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/24/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/25/2024
  • 0 very positive mentions
  • 10 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
Mentions as of
4/24/2024

Current Sentiment

  • 0 very positive mentions
  • 10 positive mentions
  • 2 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

  • No very positive mentions tracked during this time.
RTW Biotech Opportunities logo
RTW Biotech Opportunities Ltd is a venture capital fund. The fund specializes in directly investing and early-stage. The fund specializes in identifying transformative assets with high growth potential across the life sciences, biopharmaceutical and medical technology sectors. The fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.
Read More

Today's Range

Now: GBX 1.31
Low: 1.30
High: 1.31

50 Day Range

MA: GBX 1.31
Low: 1.27
High: 1.35

52 Week Range

Now: GBX 1.31
Low: 1.05
High: 1.43

Volume

355,518 shs

Average Volume

775,424 shs

Market Capitalization

£5.05 million

P/E Ratio

3.64

Dividend Yield

N/A

Beta

0.6

Frequently Asked Questions

What sell-side analysts currently cover shares of RTW Biotech Opportunities?

The following Wall Street analysts have issued research reports on RTW Biotech Opportunities in the last year:
View the latest analyst ratings for RTW.

What is the current price target for RTW Biotech Opportunities?

0 Wall Street analysts have set twelve-month price targets for RTW Biotech Opportunities in the last year. has the lowest price target set, forecasting a price of £100,000 for RTW Biotech Opportunities in the next year.
View the latest price targets for RTW.

What is the current consensus analyst rating for RTW Biotech Opportunities?

RTW Biotech Opportunities currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for RTW.

What other companies compete with RTW Biotech Opportunities?

Other companies that are similar to RTW Biotech Opportunities include Jade Road Investments, Sure Ventures, Vox Valor Capital, Third Point Investors and Alpha Growth. Learn More about companies similar to RTW Biotech Opportunities.

How do I contact RTW Biotech Opportunities' investor relations team?

RTW Biotech Opportunities' physical mailing address is 330 West 34th Street, New York, NY 10001. The company's listed phone number is 646-597-6980. The official website for RTW Biotech Opportunities is www.rtwfunds.com. Learn More about contacing RTW Biotech Opportunities investor relations.